Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Cancer "stemness"- regulating microRNAs: role, mechanisms and therapeutic potential.

Bhardwaj A, Arora S, Prajapati VK, Singh S, Singh AP.

Curr Drug Targets. 2013 Sep;14(10):1175-84. Review.

PMID:
23834145
2.

MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.

Xia H, Hui KM.

Cancer Gene Ther. 2012 Nov;19(11):723-30. doi: 10.1038/cgt.2012.58. Review.

PMID:
22975591
3.

MicroRNAs: master regulators of drug resistance, stemness, and metastasis.

Raza U, Zhang JD, Sahin O.

J Mol Med (Berl). 2014 Apr;92(4):321-36. doi: 10.1007/s00109-014-1129-2. Review.

PMID:
24509937
4.

MicroRNAs and cancer stem cells: the sword and the shield.

Sun X, Jiao X, Pestell TG, Fan C, Qin S, Mirabelli E, Ren H, Pestell RG.

Oncogene. 2014 Oct 16;33(42):4967-77. doi: 10.1038/onc.2013.492. Review.

PMID:
24240682
5.

Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?

Gunaratne PH.

Curr Stem Cell Res Ther. 2009 Sep;4(3):168-77. Review.

PMID:
19492978
6.

MicroRNAs in cancer stem cells: new regulators of stemness.

Xing F, Wu K, Watabe K.

Curr Pharm Des. 2014;20(33):5319-27. Review.

PMID:
24479802
7.

Emerging roles for modulation of microRNA signatures in cancer chemoprevention.

Neelakandan K, Babu P, Nair S.

Curr Cancer Drug Targets. 2012 Jul;12(6):716-40. Review.

PMID:
22515522
8.

Emerging role of microRNAs in cancer and cancer stem cells.

Hao J, Zhao S, Zhang Y, Zhao Z, Ye R, Wen J, Li J.

J Cell Biochem. 2014 Apr;115(4):605-10. doi: 10.1002/jcb.24702. Review.

PMID:
24166873
9.

Pancreatic cancer stem cells: new insight into a stubborn disease.

Zhan HX, Xu JW, Wu D, Zhang TP, Hu SY.

Cancer Lett. 2015 Feb 28;357(2):429-37. doi: 10.1016/j.canlet.2014.12.004. Review.

PMID:
25499079
10.

miRNA therapy targeting cancer stem cells: a new paradigm for cancer treatment and prevention of tumor recurrence.

Osaki M, Okada F, Ochiya T.

Ther Deliv. 2015 Mar;6(3):323-37. doi: 10.4155/tde.14.122. Review.

PMID:
25853308
11.

Role of microRNAs in maintaining cancer stem cells.

Garofalo M, Croce CM.

Adv Drug Deliv Rev. 2015 Jan;81:53-61. doi: 10.1016/j.addr.2014.11.014. Review.

12.

Cancer stem cells.

Yu Z, Pestell TG, Lisanti MP, Pestell RG.

Int J Biochem Cell Biol. 2012 Dec;44(12):2144-51. doi: 10.1016/j.biocel.2012.08.022. Review.

13.

The role of microRNAs in breast cancer stem cells.

Schwarzenbacher D, Balic M, Pichler M.

Int J Mol Sci. 2013 Jul 15;14(7):14712-23. doi: 10.3390/ijms140714712. Review.

14.

Targeting CSC-related miRNAs for cancer therapy by natural agents.

Bao B, Li Y, Ahmad A, Azmi AS, Bao G, Ali S, Banerjee S, Kong D, Sarkar FH.

Curr Drug Targets. 2012 Dec;13(14):1858-68. Review.

15.

Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.

Wang Z, Li Y, Ahmad A, Azmi AS, Kong D, Banerjee S, Sarkar FH.

Drug Resist Updat. 2010 Aug-Oct;13(4-5):109-18. doi: 10.1016/j.drup.2010.07.001. Review.

16.

Small players with big roles: microRNAs as targets to inhibit breast cancer progression.

Greene SB, Herschkowitz JI, Rosen JM.

Curr Drug Targets. 2010 Sep;11(9):1059-73. Review.

17.

Regulating miRNA by natural agents as a new strategy for cancer treatment.

Sethi S, Li Y, Sarkar FH.

Curr Drug Targets. 2013 Sep;14(10):1167-74. Review.

18.

MicroRNAs in cancer stem cells: current status and future directions.

Chhabra R, Saini N.

Tumour Biol. 2014 Sep;35(9):8395-405. doi: 10.1007/s13277-014-2264-7. Review.

PMID:
24964962
19.

Modulatory roles of microRNAs in the regulation of different signalling pathways in large bowel cancer stem cells.

Mamoori A, Gopalan V, Smith RA, Lam AK.

Biol Cell. 2016 Mar;108(3):51-64. doi: 10.1111/boc.201500062. Review.

PMID:
26712035
20.

MicroRNAs and cancer stem cells: therapeutic approaches and future perspectives.

Leal JA, Lleonart ME.

Cancer Lett. 2013 Sep 10;338(1):174-83. doi: 10.1016/j.canlet.2012.04.020. Review.

PMID:
22554710

Supplemental Content

Support Center